Aurora Cannabis (ACB) Cash from Discontinued Operations (2020 - 2025)
Aurora Cannabis (ACB) reported Cash from Discontinued Operations of 7.22 for Q2 2025, down 1.29% year-over-year from 7.31 in Q2 2024, and up 100.0% quarter-over-quarter from 1534094.36 in Q1 2025.
Aurora Cannabis (ACB) Cash from Discontinued Operations (2020 - 2025) Analysis & Trends
Aurora Cannabis (ACB) has 6 years of Cash from Discontinued Operations data on file, last reported at 7.22 in Q2 2025.
- Cash from Discontinued Operations for Q2 2025 came in at 7.22, down 1.29% year-over-year; the trailing twelve-month figure through Dec 2025 was 1534087.15 (down 50.99% YoY), and the FY2025 annual result was 1533913.16, up 61.31% from the prior year.
- Cash from Discontinued Operations climbed to 7.22 in Q2 2025 per ACB's latest filing, from 1534094.36 in the prior quarter.
- Over five years, Cash from Discontinued Operations peaked at 197.92 in Q3 2024 and troughed at 2441403.14 in Q2 2021.
- A 5-year average of 837529.7 and a median of 457141.74 in 2024 frame the typical range for Cash from Discontinued Operations.
- The sharpest annual moves came in 2023 and 2024: Cash from Discontinued Operations tumbled 14357734.56% in 2023, then surged 100.01% in 2024.
- A 5-year view of Cash from Discontinued Operations shows it stood at 2441403.14 in 2021, then soared by 100.0% to 7.37 in 2022, then plunged by 14357734.56% to 1057731.16 in 2023, then soared by 47.14% to 559078.18 in 2024, then surged by 100.0% to 7.22 in 2025.
- Business Quant data shows ACB's Cash from Discontinued Operations at 7.22 in Q2 2025, 1534094.36 in Q1 2025, and 559078.18 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 7.22 |
| Jun 30, 2025 | 7.22 |
| Mar 31, 2025 | -1.53 Mn |
| Mar 31, 2025 | -1.53 Mn |
| Dec 31, 2024 | -559,078.18 |
| Dec 31, 2024 | -559,078.18 |
| Sep 30, 2024 | 197.92 |
| Sep 30, 2024 | 197.92 |
| Jun 30, 2024 | 7.31 |
| Jun 30, 2024 | 7.31 |
| Mar 31, 2024 | -457,141.74 |
| Mar 31, 2024 | -457,141.74 |
| Dec 31, 2023 | -1.06 Mn |
| Dec 31, 2023 | -1.06 Mn |
| Sep 30, 2023 | -2.40 Mn |
| Sep 30, 2023 | -2.40 Mn |
| Dec 31, 2022 | 7.37 |
| Dec 31, 2022 | 7.37 |
| Sep 30, 2022 | -2.44 Mn |
| Sep 30, 2022 | -2.44 Mn |